This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
AB1-SSA1,26,33 (i) The name, address, and telephone number of a designated representative.
AB1-SSA1,26,54 (j) For the person identified as the designated representative in par. (i), a
5personal information statement that contains all of the following:
AB1-SSA1,26,66 1. The person's date and place of birth.
AB1-SSA1,26,87 2. The person's place of residence for the 7-year period immediately preceding
8the date of the application.
AB1-SSA1,26,109 3. The person's occupations, positions of employment, and offices held during
10the 7-year period immediately preceding the date of the application.
AB1-SSA1,26,1211 4. The name and addresses for each business, corporation, or other entity listed
12in subd. 3.
AB1-SSA1,26,1613 5. A statement indicating whether the person has been, during the 7-year
14period immediately preceding the date of the application, the subject of any
15proceeding for the revocation of any business or professional license and the
16disposition of the proceeding.
AB1-SSA1,26,2117 6. A statement indicating whether the person has been, during the 7-year
18period immediately preceding the date of the application, enjoined by a court, either
19temporarily or permanently, from possessing, controlling, or distributing any
20prescription drug, and a description of the circumstances surrounding the
21injunction.
AB1-SSA1,27,222 7. A description of any involvement by the person during the past 7 years with
23any business, including investments other than the ownership of stock in a publicly
24traded company or mutual fund, that manufactured, administered, prescribed,

1distributed, or stored pharmaceutical products or drugs, and a list of any lawsuits
2in which such a business was named as a party.
AB1-SSA1,27,83 8. A description of any misdemeanor or felony criminal offense of which the
4person was, as an adult, found guilty, whether adjudication of guilt was withheld or
5the person pleaded guilty or no contest. If the person is appealing a criminal
6conviction, the application shall include a copy of the notice of appeal, and the person
7shall submit a copy of the final disposition of the appeal not more than 15 days after
8a final disposition is reached.
AB1-SSA1,27,109 9. A photograph of the person taken within the 12-month period immediately
10preceding the date of the application.
AB1-SSA1,27,1511 (k) A statement that each facility used by the applicant for 3rd-party logistics
12provider services has been inspected in the 3-year period immediately preceding the
13date of the application by the board, a pharmacy examining board of another state,
14the National Association of Boards of Pharmacy, or another accrediting body
15recognized by the board, with the date of each such inspection.
AB1-SSA1,27,18 16(3) Licensure. The board shall grant a license to an applicant to act as a
173rd-party logistics provider or an out-of-state 3rd-party logistics provider if all of
18the following apply:
AB1-SSA1,27,1919 (a) The applicant pays the fee specified in s. 440.05 (1).
AB1-SSA1,27,2220 (b) The inspections conducted pursuant to sub. (2) (k) satisfy requirements
21adopted by the board for 3rd-party logistics providers or out-of-state 3rd-party
22logistics providers.
AB1-SSA1,27,2423 (c) All of the following apply to each person identified by the applicant as a
24designated representative:
AB1-SSA1,27,2525 1. The person is at least 21 years old.
AB1-SSA1,28,3
12. The person has been employed full time for at least 3 years in a pharmacy
2or with a wholesale prescription drug distributor in a capacity related to the
3dispensing of and distribution of, and record keeping related to, prescription drugs.
AB1-SSA1,28,44 3. The person is employed by the applicant full time in a managerial position.
AB1-SSA1,28,105 4. The person is physically present at the 3rd-party logistics provider's or
6out-of-state 3rd-party logistics provider's facility during regular business hours
7and is involved in and aware of the daily operation of the 3rd-party logistics provider
8or the out-of-state 3rd-party logistics provider. This subdivision does not preclude
9the person from taking authorized sick leave and vacation time or from being absent
10from the facility for other authorized business or personal purposes.
AB1-SSA1,28,1211 5. The person is actively involved in and aware of the daily operation of the
123rd-party logistics provider or the out-of-state 3rd-party logistics provider.
AB1-SSA1,28,1713 6. The person is a designated representative for only one applicant at any given
14time. This subdivision does not apply if more than one 3rd-party logistics provider
15or out-of-state 3rd-party logistics provider is located at the facility and the
163rd-party logistics providers or out-of-state 3rd-party logistics providers located at
17the facility are members of an affiliated group.
AB1-SSA1,28,1918 7. The person has not been convicted of violating any federal, state, or local law
19relating to distribution of a controlled substance.
AB1-SSA1,28,2020 8. The person has not been convicted of a felony.
AB1-SSA1,28,2521 9. The person submits to the department 2 fingerprint cards, each bearing a
22complete set of the applicant's fingerprints. The department of justice shall provide
23for the submission of the fingerprint cards to the federal bureau of investigation for
24purposes of verifying the identity of the person and obtaining the person's criminal
25arrest and conviction record.
AB1-SSA1,29,2
1(d) The applicant satisfies any other requirements established by the board by
2rule.
AB1-SSA1,29,8 3(4) Rules. The board shall promulgate rules implementing this section. The
4rules shall ensure compliance with the federal drug supply chain security act, 21
5USC 360eee
, et seq. The board may not promulgate rules that impose requirements
6more strict than the federal drug supply chain security act, or any regulations passed
7under the federal drug supply chain security act. The board may not promulgate
8rules that require a license under this section.
AB1-SSA1,29,12 9(5) Access to records. Applications for licensure under this section are not
10subject to inspection or copying under s. 19.35, and may not be disclosed to any
11person except as necessary for compliance with and enforcement of the provisions of
12this chapter.
AB1-SSA1,29,17 13(6) Inspections. A 3rd-party logistics provider or an out-of-state 3rd-party
14logistics provider shall allow the board and authorized federal, state, and local law
15enforcement officials to enter and inspect its facilities and delivery vehicles, to audit
16its records and written operating procedures, and to confiscate prescription drugs
17and records to the extent authorized by law, rule, or regulation.
AB1-SSA1,29,22 18(7) Applicability. This section does not apply if the board determines that the
19federal food and drug administration has established a licensing program for
203rd-party logistics providers under 21 USC 360eee-3 and that licensing by this state
21of resident 3rd-party logistics providers is not required for a resident 3rd-party
22logistics provider to provide 3rd-party logistics provider services in another state.
AB1-SSA1,34 23Section 34 . 450.11 (5) (br) 2. d. of the statutes is amended to read:
AB1-SSA1,30,3
1450.11 (5) (br) 2. d. A pharmacist may not extend a prescription order under
2subd. 1. for a particular patient if a prescription order was previously extended under
3subd. 1. for that patient during the applicable period described in subd. 3.
AB1-SSA1,35 4Section 35 . 450.11 (5) (br) 3. of the statutes is renumbered 450.11 (5) (br) 3.
5(intro.) and amended to read:
AB1-SSA1,30,66 450.11 (5) (br) 3. (intro.) This paragraph applies only during as follows:
AB1-SSA1,30,9 7a. During the public health emergency declared on March 12, 2020, by
8executive order 72, and for 30 days after the conclusion of that public health
9emergency. During that time,
AB1-SSA1,30,11 104. While this paragraph applies as specified in subd. 3., it supersedes par. (bm)
11to the extent of any conflict.
AB1-SSA1,36 12Section 36 . 450.11 (5) (br) 3. b. of the statutes is created to read:
AB1-SSA1,30,1413 450.11 (5) (br) 3. b. During the period beginning on the effective date of this
14subd. 3. b. .... [LRB inserts date], and ending on June 30, 2021.
AB1-SSA1,37 15Section 37 . 609.205 (2) (intro.) and (a) of the statutes are amended to read:
AB1-SSA1,30,2116 609.205 (2) (intro.) All of the following apply to a defined network plan or
17preferred provider plan during the state of emergency related to public health
18declared under s. 323.10 on March 12, 2020, by executive order 72, and for the 60 days
19following the date that the state of emergency terminates
until the conclusion of a
20national emergency declared by the U.S. president under 50 USC 1621 in response
21to the 2019 novel coronavirus or June 30, 2021, whichever is earlier
:
AB1-SSA1,31,422 (a) The plan may not require an enrollee to pay, including cost sharing, for a
23service, treatment, or supply provided by a provider that is not a participating
24provider in the plan's network of providers more than the enrollee would pay if the
25service, treatment, or supply is provided by a provider that is a participating

1provider. This subsection applies to any service, treatment, or supply that is related
2to diagnosis or treatment for COVID-19 and to any service, treatment, or supply that
3is provided by a provider that is not a participating provider because a participating
4provider is unavailable due to the public health emergency.
AB1-SSA1,38 5Section 38 . 609.205 (3) (intro.) of the statutes is amended to read:
AB1-SSA1,31,136 609.205 (3) (intro.) During the state of emergency related to public health
7declared under s. 323.10 on March 12, 2020, by executive order 72, and for the 60 days
8following the date that the state of emergency terminates
Until the conclusion of a
9national emergency declared by the U.S. president under 50 USC 1621 in response
10to the 2019 novel coronavirus or June 30, 2021, whichever is earlier
, all of the
11following apply to any health care provider or health care facility that provides a
12service, treatment, or supply to an enrollee of a defined network plan or preferred
13provider plan but is not a participating provider of that plan:
AB1-SSA1,39 14Section 39 . 632.895 (14g) (b) of the statutes is amended to read:
AB1-SSA1,31,2215 632.895 (14g) (b) Before March 13, 2021 Until the conclusion of a national
16emergency declared by the U.S. president under 50 USC 1621 in response to the 2019
17novel coronavirus or June 30, 2021, whichever is earlier
, every disability insurance
18policy, and every self-insured health plan of the state or of a county, city, town,
19village, or school district, that generally covers vaccination and testing for infectious
20diseases shall provide coverage of testing for COVID-19 and vaccination against the
21SARS-CoV-2 coronavirus
without imposing any copayment or coinsurance on the
22individual covered under the policy or plan.
AB1-SSA1,40 23Section 40 . 632.895 (16v) (a) (intro.) of the statutes is amended to read:
AB1-SSA1,32,524 632.895 (16v) (a) (intro.) During the period covered by the state of emergency
25related to public health declared by the governor on March 12, 2020, by executive

1order 72
Until June 30, 2021, an insurer offering a disability insurance policy that
2covers prescription drugs, a self-insured health plan of the state or of a county, city,
3town, village, or school district that covers prescription drugs, or a pharmacy benefit
4manager acting on behalf of a policy or plan may not do any of the following in order
5to maintain coverage of a prescription drug:
AB1-SSA1,41 6Section 41 . 655.0025 of the statutes is created to read:
AB1-SSA1,32,12 7655.0025 Participation during COVID-19 national emergency. Until
8the conclusion of a national emergency declared by the U.S. president under 50 USC
91621
in response to the 2019 novel coronavirus or June 30, 2021, whichever is earlier,
10all of the following apply to a physician or nurse anesthetist for whom this state is
11not a principal place of practice but who is authorized to practice in this state on a
12temporary basis:
AB1-SSA1,32,16 13(1) The physician or nurse anesthetist may fulfill the requirements of s. 655.23
14(3) (a) by filing with the commissioner a certificate of insurance for a policy of health
15care liability insurance issued by an insurer that is authorized in a jurisdiction
16accredited by the National Association of Insurance Commissioners.
AB1-SSA1,32,18 17(2) The physician or nurse anesthetist may elect, in the manner designated by
18the commissioner by rule under s. 655.004, to be subject to this chapter.
AB1-SSA1,42 19Section 42 . 895.476 of the statutes is created to read:
AB1-SSA1,32,21 20895.476 Civil liability exemption; exposure to the novel coronavirus
21SARS-CoV-2 or COVID-19.
(1) In this section:
AB1-SSA1,32,2422 (a) “COVID-19” means the infection caused by the novel coronavirus
23SARS-CoV-2 or by any viral strain originating from SARS-CoV-2, and conditions
24associated with the infection.
AB1-SSA1,33,5
1(b) “Entity” means a partnership, corporation, association, governmental
2entity, tribal government, tribal entity, or other legal entity, including a school,
3institution of higher education, or nonprofit organization. “Entity” includes an
4employer or business owner, employee, agent, or independent contractor of the
5entity, regardless of whether the person is paid or an unpaid volunteer.
AB1-SSA1,33,10 6(2) Beginning March 1, 2020, an entity is immune from civil liability for the
7death of or injury to any individual or damages caused by an act or omission resulting
8in or relating to exposure, directly or indirectly, to the novel coronavirus identified
9as SARS-CoV-2 or COVID-19 in the course of or through the performance or
10provision of the entity's functions or services.
AB1-SSA1,33,15 11(3) Subsection (2) does not apply if the act or omission involves reckless or
12wanton conduct or intentional misconduct. Noncompliance with any applicable
13national, state, or local order requiring entities to close or limit capacity does not
14constitute reckless or wanton conduct or intentional misconduct for purposes of this
15section.
AB1-SSA1,33,18 16(4) Immunity under this section is in addition to, not in lieu of, other immunity
17granted by law, and nothing in this section limits immunity granted under any other
18provision of law, including immunity granted under s. 893.80 (4).
AB1-SSA1,43 19Section 43. 895.4801 (2) (a) (intro.) of the statutes is created to read:
AB1-SSA1,33,2020 895.4801 (2) (a) (intro.) One of the following applies:
AB1-SSA1,44 21Section 44 . 895.4801 (2) (a) of the statutes is renumbered 895.4801 (2) (a) 1.
AB1-SSA1,45 22Section 45 . 895.4801 (2) (a) 2. of the statutes is created to read:
AB1-SSA1,34,323 895.4801 (2) (a) 2. Beginning on July 10, 2020, the action or omission is
24committed while the professional, provider, employee, agent, or contractor is
25providing services during any public health emergency declared under 42 USC 247d

1by the secretary of the federal department of health and human services in response
2to the 2019 novel coronavirus or the 90 days after the expiration of such an
3emergency.
AB1-SSA1,46 4Section 46 . 895.4801 (2) (b) 1. of the statutes is amended to read:
AB1-SSA1,34,75 895.4801 (2) (b) 1. Any direction, guidance, recommendation, or other
6statement made by a federal, state, or local official to address or in response to the
7emergency or disaster declared as described under par. (a).
AB1-SSA1,9101 8Section 9101. Nonstatutory provisions; Administration.
AB1-SSA1,34,99 (1) Position transfers.
AB1-SSA1,34,1110 (a) In this subsection, “state agency” means any office, commission, board,
11department, or independent agency in the executive branch of state government.
AB1-SSA1,34,1712 (b) The secretary of administration may transfer any employee from one state
13agency to another state agency to provide services for the receiving state agency. The
14receiving state agency shall pay all salary and fringe benefit costs of the employee
15during the time he or she is providing services for the receiving state agency. Any
16transfer by the secretary under this paragraph shall remain in effect until rescinded
17by the secretary or June 30, 2021, whichever occurs first.
AB1-SSA1,34,2218 (c) If an employee is transferred under par. (b), the receiving agency may not
19increase the employee's salary at the time of transfer or during the time he or she is
20providing services for the receiving agency and the transferring agency may not
21increase the employee's salary at the time the employee returns to the transferring
22agency.
AB1-SSA1,35,323 (d) The secretary of administration shall submit a report to the joint committee
24on finance no later than June 1, 2021, that provides information on all employee
25transfers, both permanent and temporary, under par. (b ). The report shall specify

1the number of employees transferred, the title of each employee transferred, the title
2the employee assumed at the receiving agency, and the reasons for each employee
3transfer.
AB1-SSA1,9106 4Section 9106. Nonstatutory provisions; Children and Families.
AB1-SSA1,35,105 (1) Child care and development fund block grant funds. The federal Child
6Care and Development Fund block grant funds received under the federal
7Consolidated Appropriations Act, 2021, P.L. 116-260, shall be credited to the
8appropriations under s. 20.437 (1) (mc) and (md). No moneys credited under this
9subsection may be encumbered or expended except as provided under s. 16.54 (2) (a)
102.
AB1-SSA1,9119 11Section 9119. Nonstatutory provisions; Health Services.
AB1-SSA1,35,1212 (1) Payment for hospitals for nursing facility care.
AB1-SSA1,35,1613 (a) In this subsection, “public health emergency period” means the period
14ending on June 30, 2021, or the termination of any public health emergency declared
15under 42 USC 247d by the secretary of the federal department of health and human
16services in response to the 2019 novel coronavirus, whichever is earlier.
AB1-SSA1,35,2117 (b) During the public health emergency period, subject to par. (c), the
18department of health services shall provide, under the Medical Assistance program,
19reimbursement at the statewide average per-diem rate paid to nursing facilities or
20a supplemental payment to hospitals for providing nursing-facility-level care when
21all of the following criteria apply:
AB1-SSA1,36,2 221. The individual for whom the hospital provided nursing-facility-level care
23is enrolled in the Medical Assistance program, has been admitted on an inpatient
24basis to the hospital, is eligible for discharge after receiving care in the hospital,
25requires nursing-facility-level care upon discharge, and due to the hospital being

1unable to locate a nursing facility that accepts the individual for admission, is unable
2to be transferred to a nursing facility.
AB1-SSA1,36,4 32. The services provided to the individual described under subd. 1 . are custodial
4care for which federal financial participation is approved.
AB1-SSA1,36,6 53. The hospital notifies the department of health services that it is
6participating as a swing bed hospital under the Medical Assistance program.
AB1-SSA1,36,147 (c) The department of health services shall use the same standards and criteria
8for determining whether a hospital is eligible for reimbursement or a supplemental
9payment under par. (b) as are used by the federal Medicare program under 42 USC
101395
et seq. for the payment for use of swing beds or, for any hospital that is not a
11critical access hospital, under the terms of a federal waiver approved under section
121135 of the federal social security act. The department shall seek any approval from
13the federal government necessary to implement the reimbursement under this
14subsection.
AB1-SSA1,36,1515 (2) Payment for outpatient services provided by hospitals.
AB1-SSA1,36,2116 (a) Until the conclusion of a public health emergency declared under 42 USC
17247d
by the secretary of the federal department of health and human services in
18response to the 2019 novel coronavirus or until June 30, 2021, whichever is earlier,
19the department of health services shall provide reimbursement or a supplemental
20payment under the Medical Assistance program to a hospital for providing any
21outpatient service when all of the following criteria are satisfied:
AB1-SSA1,36,25 221. The facility at which the outpatient service is performed is operated by the
23hospital and certified under the Medicare program under 42 USC 1395 et seq.,
24including under the terms of a federal waiver approved under section 1135 of the
25federal social security act, for outpatient services.
AB1-SSA1,37,3
12. The outpatient service is reimbursable when provided in the hospital's
2inpatient facility but is not provided at the inpatient facility due to reasons
3associated with the 2019 novel coronavirus pandemic.
AB1-SSA1,37,5 43. The outpatient service is one for which federal financial participation is
5approved.
AB1-SSA1,37,76 (b) The department of health services may not include in a reimbursement
7under par. (a) payments under s. 49.45 (3) (e) 11. or 12. or (59).
AB1-SSA1,37,108 (c) The department of health services shall seek any approval from the federal
9department of health and human services that is necessary to provide the
10reimbursement or a supplemental payment in accordance with this subsection.
AB1-SSA1,37,1611 (3) Coverage of vaccinations under SeniorCare. By January 15, 2021, the
12department of health services shall cover and provide reimbursement for
13vaccinations under the program under s. 49.688 in accordance with 2019 Wisconsin
14Act 185
, sections 15 to 17, regardless of whether a waiver related to coverage or
15reimbursement of vaccinations is granted by the federal department of health and
16human services.
Loading...
Loading...